Paper42075889
When Red Blood Cells Meet Carbon Monoxide: Yin and Yang in Medicines and Pharmaceuticals.
Nagasaki T and 3 others. Pharmaceuticals (Basel), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. When Red Blood Cells Meet Carbon Monoxide: Yin and Yang in Medicines and Pharmaceuticals. Papers, record 42075889. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42075889
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- When Red Blood Cells Meet Carbon Monoxide: Yin and Yang in Medicines and Pharmaceuticals.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References147
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39334780 | Carbon Monoxide: A Pleiotropic Redox Regulator of Life and Death. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39334780 | PubMed |
| 2 | 36802431 | A synthetic porphyrin as an effective dual antidote against carbon monoxide and cyanide poisoning. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/36802431 | PubMed |
| 3 | 41599772 | Bovine Mastitis Therapy at a Crossroads: Pharmacokinetic Barriers, Biofilms, Antimicrobial Resistance, and Emerging Solutions. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41599772 | PubMed |
| 4 | 14558472 | The global allostery model of hemoglobin: an allosteric mechanism involving homotropic and heterotropic interactions. | C R Biol | 2003 | https://conductscience.org/library/papers/14558472 | PubMed |
| 5 | 24811261 | Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced pulmonary fibrosis. | Biomaterials | 2014 | https://conductscience.org/library/papers/24811261 | PubMed |
| 6 | 41643237 | Molybdenum(II) allyl dicarbonyl complexes with 3-(2-pyridyl)pyrazole as potential CO-releasing molecules, antibacterial and antitumoral agents. | J Inorg Biochem | 2026 | https://conductscience.org/library/papers/41643237 | PubMed |
| 7 | 38657755 | Carbon monoxide-loaded cell therapy as an exercise mimetic for sarcopenia treatment. | Free Radic Biol Med | 2024 | https://conductscience.org/library/papers/38657755 | PubMed |
| 8 | 31606731 | Effect of Hyperbaric Oxygen on Neurologic Sequelae and All-Cause Mortality in Patients with Carbon Monoxide Poisoning: A Meta-Analysis of Randomized Controlled Trials. | Med Sci Monit | 2019 | https://conductscience.org/library/papers/31606731 | PubMed |
| 9 | 30007887 | A thiol-reactive Ru(II) ion, not CO release, underlies the potent antimicrobial and cytotoxic properties of CO-releasing molecule-3. | Redox Biol | 2018 | https://conductscience.org/library/papers/30007887 | PubMed |
| 10 | 18827742 | Hemoglobin vesicles and red blood cells as carriers of carbon monoxide prior to oxygen for resuscitation after hemorrhagic shock in a rat model. | Shock | 2009 | https://conductscience.org/library/papers/18827742 | PubMed |
| 11 | 40727821 | Synthesis, Characterization, Computational Evaluation, CO-Releasing Properties, and Molecular Docking Interactions of New [Mn(CO)3(bpy)L]PF6‑Type Molecules. | ACS Omega | 2025 | https://conductscience.org/library/papers/40727821 | PubMed |
| 12 | 30689450 | Determination of carboxyhemoglobin half-life in patients with carbon monoxide toxicity treated with high flow nasal cannula oxygen therapy. | Clin Toxicol (Phila) | 2019 | https://conductscience.org/library/papers/30689450 | PubMed |
| 13 | 1194155 | Predicting the carboxyhemoglobin levels resulting from carbon monoxide exposures. | J Appl Physiol | 1975 | https://conductscience.org/library/papers/1194155 | PubMed |
| 14 | 33790808 | How Do Red Blood Cells Die? | Front Physiol | 2021 | https://conductscience.org/library/papers/33790808 | PubMed |
| 15 | 31971171 | Nitro reduction-based fluorescent probes for carbon monoxide require reactivity involving a ruthenium carbonyl moiety. | Chem Commun (Camb) | 2020 | https://conductscience.org/library/papers/31971171 | PubMed |
| 16 | 35056952 | Liposomal Artificial Red Blood Cell-Based Carbon Monoxide Donor Is a Potent Renoprotectant against Cisplatin-Induced Acute Kidney Injury. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/35056952 | PubMed |
| 17 | 36802675 | Toward "CO in a Pill": Silica-Immobilized Organic CO Prodrugs for Studying the Feasibility of Systemic Delivery of CO via In Situ Gastrointestinal CO Release. | Mol Pharm | 2023 | https://conductscience.org/library/papers/36802675 | PubMed |
| 18 | 20444253 | Carbon monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats. | BMC Gastroenterol | 2010 | https://conductscience.org/library/papers/20444253 | PubMed |
| 19 | 30518685 | A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDS. | JCI Insight | 2018 | https://conductscience.org/library/papers/30518685 | PubMed |
| 20 | 41618704 | Carbon monoxide treatment rescues leukofiltration and preserves storage quality of red blood cell concentrates from sickle cell trait donors. | Transfusion | 2026 | https://conductscience.org/library/papers/41618704 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42075889
GET https://conductscience.org/api/papers/v1/42075889/references?page=2